Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of trifarotene cream in Chinese subjects with acne vulgaris
CTR20252487Phase 3Active
- Sponsor
- Galderma
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trifarotene in acne vulgaris, sponsored by Galderma. Started Sep 2025; status: active.
02
Drugs
trifarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20252487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252487.